SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950135-04-001821
Filing Date
2004-04-12
Accepted
2004-04-12 17:17:12
Documents
9
Period of Report
2004-06-23
Effectiveness Date
2004-04-12

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS, INC. FORM DEF 14A b50018apdef14a.htm DEF 14A 351709
3 GRAPHIC b50018apb5001800.gif GRAPHIC 4300
4 GRAPHIC b50018apb5001801.gif GRAPHIC 2448
5 GRAPHIC b50018apb5001804.gif GRAPHIC 3958
6 GRAPHIC b50018apb5001802.gif GRAPHIC 2288
7 GRAPHIC b50018apb5001803.gif GRAPHIC 7466
8 GRAPHIC b50018apb5001899.gif GRAPHIC 2288
9 GRAPHIC b50018apb5001806.gif GRAPHIC 2780
10 GRAPHIC b50018apb5001805.gif GRAPHIC 2448
  Complete submission text file 0000950135-04-001821.txt   382164
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 333-76486 | Film No.: 04729124
SIC: 2836 Biological Products, (No Diagnostic Substances)